No Data
Rating information (Target Price change - part 2) = SUMCO, Chugai Pharmaceutical, ETC.
◎ Mizuho Securities (three levels: Buy > Hold > underperform) SUMCO <3436.T> -- "Buy" → "Buy", 2300 yen → 2100 yen UBE <4208.T> -- "Buy" → "Buy", 3600 yen → 3000 yen M3 <2413.T> -- "Hold" → "Hold", 1600 yen → 1900 yen ◎ Morgan Stanley MUFG Securities (three levels: Overweight > Equal Weight > Underweight) Chugai Pharmaceutical <4519.T> -- "Overweight"
Wasatch International Growth's Strategic Moves: Significant Reduction in GMO Payment Gateway Inc
GMO Payment Gateway: 1st quarter financial results briefing for the fiscal year ending September 2025
Recruit Holdings has revised its 2025/3 operating profit upward to 488 billion yen from 442.7 billion yen.
Recruit Holdings <6098> announced a revision of its financial estimates for the fiscal year ending in March 2025. Revenue has been revised upward from 3 trillion 468.7 billion yen to 3 trillion 560 billion yen, and operating profit has been revised upward from 442.7 billion yen to 488 billion yen. The HR Technology business, centered around the US job search site "Indeed," is performing well, contributing to increased revenue per paid job advertisement. Matching & solutions such as the real estate site "SUUMO" and the beauty reservation site "Hot Pepper View Inc" are also contributing.
Key points of the PTS on the 12th = Rakuten Bank, GMO R&A, Sumitomo Construction.
▽ Rakuten Bank <5838.T>, Earnings Reports and Financial Estimates revisions ▽ GMO R&A <3695.T>, Earnings Reports and Financial Estimates and Dividends forecast revisions as well as the introduction of a Shareholder benefit system ▽ Mizuho Construction <1821.T>, Earnings Reports and Financial Estimates revisions ▽ Japan Electrical Construction <1950.T>, Dividend increase and share buyback ▽ JGC HD <1963.T>, Earnings Reports and Financial Estimates revisions ▽ Sasmmed <4263.T>, achievement of milestones related to a joint research and development and sales agreement with Aska Pharmaceutical ▽ SIGG <
GMO Payment Gateway: Summary of financial results for the 1st quarter of the fiscal year ending September 2025 [IFRS] (consolidated)